Dysphagia Management In Head And Neck Cancers A Manual And Atlas

Dysphagia Management In Head And Neck Cancers A Manual And Atlas - Updated: May 2003. In British Columbia, incidence of cancers of the head and neck region is 22.9/100,000 in males and 14.9/100,000 in females. Head and neck cancers are a heterogeneous group of tumours, consisting predominently of squamous cancers of the lip, mouth, pharynx, larynx and cervical esophagus, adenocarcinomas of the major and minor. Reviewed Sep 2016. Guidelines for treating these cancers were developed by the Head & Neck Tumour Group. For health professional information on treating this cancer, please see our Cancer Management Guidelines.. Head and neck cancer treatment is complex and combined modality therapy is common. The involvement of an experienced multidisciplinary team (MDT) in the initial development and ongoing evaluation of the treatment plan, and the management of.

Head and neck cancer treatment is complex and combined modality therapy is common. The involvement of an experienced multidisciplinary team (MDT) in the initial development and ongoing evaluation of the treatment plan, and the management of. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

---

---

---

---